+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pediatric Health Market by Product Type, Disease Type, Distribution Channel, End User, Age Group - Global Forecast to 2030- Product Image
Pediatric Health Market by Product Type, Disease Type, Distribution Channel, End User, Age Group - Global Forecast to 2030- Product Image
Sale

Pediatric Health Market by Product Type, Disease Type, Distribution Channel, End User, Age Group - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666270
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Pediatric Health Market grew from USD 113.63 billion in 2024 to USD 123.07 billion in 2025. It is expected to continue growing at a CAGR of 8.16%, reaching USD 181.98 billion by 2030.

Unlocking the Future of Pediatric Health

Pediatric health is undergoing an unprecedented evolution fueled by shifting demographics, technological breakthroughs, and rising expectations from caregivers and clinicians alike. The convergence of digital health platforms with advanced diagnostics is fostering a new era of early intervention and personalized care. As birth rates fluctuate and chronic conditions emerge at younger ages, stakeholders from device manufacturers to pharmaceutical developers must adapt strategies to align with an increasingly complex ecosystem. This report offers a panoramic view of the pediatric market trajectory, illuminating key factors shaping supply chains, innovation pipelines, and therapeutic priorities.

By examining regulatory reforms, reimbursement trends, and emerging patient needs, this executive summary sets the stage for a deeper exploration of market dynamics. Each subsequent section dissects critical drivers, from transformative shifts to regional variances, weaving together a narrative that empowers decision-makers to navigate uncertainty with confidence. Whether you are a research and development leader, a market access strategist, or an investor evaluating growth opportunities, these insights will serve as the foundational blueprint for informed action and sustainable success in the pediatric health landscape.

Revolutionizing Pediatric Care Through Key Shifts

The pediatric health sector is being redefined by a series of transformative shifts that span technological innovation, policy realignment, and evolving consumer behaviors. Breakthroughs in imaging devices now allow clinicians to detect congenital anomalies with higher precision and lower radiation exposure. Concurrently, the integration of molecular diagnostics into routine screening protocols is enabling rapid, point-of-care identification of infectious agents, reducing time-to-treatment for vulnerable patients. In the pharmaceutical realm, advances in biologics and vaccine development are addressing age-specific immunological challenges previously considered insurmountable.

On the policy front, regulatory pathways are becoming more adaptive, incorporating real-world evidence and accelerated approval mechanisms to bring critical therapies to children faster. Digital engagement platforms and telehealth services are reshaping care delivery, facilitating remote monitoring and empowering parents to participate more actively in treatment plans. These converging forces are not merely incremental; they represent a quantum leap toward a more proactive, precision-driven model of pediatric care that places patient outcomes at the center of every innovation.

Mitigating Tariff Turbulence in Pediatric Supply Chains

The imposition of United States tariffs in early 2025 has introduced significant headwinds into the pediatric health supply chain, elevating costs for critical components and finished products alike. Manufacturers of imaging and monitoring devices have encountered surcharges on imported sensors and semiconductors, while diagnostics firms face increased fees on reagents and assay kits. Biologic drug producers are contending with higher expenses for active pharmaceutical ingredients sourced from overseas facilities, compelling firms to reassess sourcing strategies and consider reshoring or nearshoring alternatives.

These cumulative tariff impacts reverberate downstream, influencing pricing negotiations with hospitals, pharmacies, and specialty centers. Payers are beginning to scrutinize reimbursement models, seeking evidence of cost-efficiencies to justify premium pricing. In response, industry leaders are forging strategic alliances with domestic suppliers, investing in modular production lines, and exploring dual-sourcing frameworks to mitigate risk. This adaptive approach not only cushions the financial effects of tariffs but also reinforces supply chain resilience, ensuring continuous access to life-saving pediatric interventions.

Deep Dive Into Market Segment Dynamics

A nuanced understanding of market segmentation is crucial for crafting targeted strategies that resonate with diverse stakeholder needs. When viewed through the lens of product type, the landscape encompasses a trio of pillars: devices, diagnostics, and drugs. Imaging devices, monitoring systems, and surgical instruments form the infrastructure of clinical interventions, while molecular and point-of-care diagnostics drive rapid decision-making at the bedside. The pharmaceutical domain is further delineated by biologics, small molecules, and vaccines, each category governed by unique development cycles and regulatory frameworks.

Disease-centric segmentation highlights five primary categories: endocrine disorders, gastrointestinal conditions, infectious diseases, neurology, and respiratory ailments. Within infectious diseases, stakeholders must navigate the intricacies of bacterial, parasitic, and viral subtypes, tailoring solutions to address Staphylococcal, Streptococcal, Malaria, Respiratory Syncytial Virus, and Rotavirus infections with precision. Distribution channels range from hospital pharmacies that handle complex formulations to the growing realm of online and retail pharmacies optimizing patient convenience. End-user insights reveal distinct operational models across multi-specialty clinics, pediatric clinics, home care settings, general hospitals, pediatric hospitals, and specialty centers. Finally, age group segmentation captures the shifting needs of infants, toddlers, children, and adolescents, each phase subdivided to ensure that product design, dosing regimens, and engagement strategies align with developmental and behavioral considerations.

Exploring Regional Drivers of Pediatric Health

Regional dynamics exert a powerful influence on pediatric health trends, regulatory landscapes, and market maturation rates. In the Americas, robust innovation ecosystems in North America are complemented by emerging research hubs in Latin America, where public-private partnerships are accelerating access to essential therapies and diagnostics. Europe, the Middle East, and Africa present a tapestry of regulatory frameworks, from the stringent approval processes of the European Union to the rapidly evolving health infrastructure across the Gulf Cooperation Council and Sub-Saharan Africa. These regions are witnessing a surge in telehealth adoption, driven by the need to bridge geographic and resource gaps.

The Asia-Pacific corridor illustrates a dual narrative of technological leadership and access challenges. Developed markets like Japan, South Korea, and Australia are pioneering digital integration, while populous nations such as China and India balance rapid urbanization with ongoing efforts to expand pediatric care into rural communities. Cross-border collaborations and localized manufacturing initiatives are reshaping supply chains, enabling economies of scale and driving down unit costs. Understanding these distinct regional contours is essential for companies seeking to tailor product portfolios, market entry strategies, and partnership models to the varied needs of pediatric health stakeholders across the globe.

Profiling Pioneers Transforming Pediatric Markets

The competitive landscape of pediatric health is marked by a blend of established conglomerates and emerging specialists, each contributing to the sector’s rapid evolution. Major device manufacturers are channeling resources into next-generation imaging and monitoring platforms, forging partnerships with software developers to integrate artificial intelligence for enhanced diagnostic accuracy. In the diagnostics arena, leading firms are expanding their molecular and point-of-care portfolios through mergers, acquisitions, and co-development agreements, targeting high-burden infectious diseases and genetic screening applications.

Pharmaceutical innovators are prioritizing biologics and novel vaccine platforms that address age-specific immunological responses, while also exploring small-molecule therapies for rare pediatric disorders. Strategic collaborations between biopharma entities and academic institutions are accelerating the translation of cutting-edge research into clinical candidates. Concurrently, a host of agile biotech start-ups is disrupting traditional models with platform technologies designed for rapid scale-up and modular deployment. These collective efforts underscore a competitive environment that rewards both deep pockets and nimble execution, offering multiple pathways to market leadership and sustained growth in pediatric health.

Strategic Imperatives for Leadership in Pediatric Health

To thrive amid this dynamic landscape, industry leaders must embrace a set of strategic imperatives that balance innovation with operational resilience. Prioritizing investments in modular manufacturing facilities within cost-effective regions can mitigate tariff pressures and respond more swiftly to demand fluctuations. Developing interoperable point-of-care platforms that integrate diagnostics, telehealth, and remote monitoring is essential for capturing value across care pathways and enhancing patient engagement.

Building strategic alliances with regional distributors and healthcare systems accelerates market penetration while enabling tailored access models. Leaders should refine pricing and reimbursement strategies by leveraging real-world evidence to demonstrate value and secure favorable formulary placements. Cultivating patient-centric product design and support services, particularly for chronic and rare pediatric conditions, fosters long-term loyalty and improves adherence. Finally, maintaining a proactive stance on regulatory intelligence and policy advocacy ensures that companies can capitalize on emerging incentives and navigate evolving frameworks with agility and confidence.

Ensuring Rigor with a Robust Research Framework

This analysis is grounded in a rigorous research framework that combines qualitative and quantitative methodologies to deliver robust, actionable insights. Primary research included in-depth interviews with clinicians, payers, and industry experts, supplemented by advisory panels convened to validate emerging trends and competitive developments. Secondary research encompassed a comprehensive review of peer-reviewed journals, regulatory filings, industry white papers, and public financial disclosures.

Data triangulation techniques were applied to reconcile disparate sources, ensuring consistency across thematic findings. Market segmentation and sizing were derived through a top-down approach, cross-checked with bottom-up data from leading suppliers and end users. Regional analysis leveraged economic indicators, healthcare expenditure statistics, and patient demographics to map growth trajectories. Throughout the process, adherence to strict quality control protocols and peer reviews guaranteed the accuracy and relevance of insights presented in this report.

Charting the Path Forward for Pediatric Innovation

The pediatric health sector stands at a defining moment characterized by profound shifts in technology, regulation, and patient engagement. The interplay of these factors creates both challenges and opportunities for stakeholders committed to improving outcomes for the youngest and most vulnerable populations. By synthesizing insights across transformative shifts, tariff impacts, segmentation dynamics, regional drivers, and competitive forces, this report offers a cohesive roadmap for strategic decision-making.

Future success will hinge on the ability to integrate advanced diagnostics with personalized therapeutics, optimize supply chain resilience, and tailor market entry strategies to distinct regional landscapes. Organizations that align their portfolios with evolving care models and leverage data-driven evidence to demonstrate value will emerge as leaders in a market poised for sustained growth and lasting impact. The path forward is clear: informed, agile, and patient-centric approaches will define the next frontier in pediatric health innovation.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Devices
      • Imaging Devices
      • Monitoring Devices
      • Surgical Instruments
    • Diagnostics
      • Molecular Diagnostics
      • Point Of Care
    • Drugs
      • Biologics
      • Small Molecule
      • Vaccines
  • Disease Type
    • Endocrine
    • Gastrointestinal
    • Infectious
      • Bacterial
        • Staphylococcal Infections
        • Streptococcal Infections
      • Parasitic
        • Malaria
      • Viral
        • Respiratory Syncytial Virus
        • Rotavirus
    • Neurology
    • Respiratory
  • Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • End User
    • Clinics
      • Multi Specialty Clinics
      • Pediatric Clinics
    • Home Care
    • Hospitals
      • General Hospitals
      • Pediatric Hospitals
    • Specialty Centers
  • Age Group
    • Adolescents
      • Early Adolescents
      • Late Adolescents
    • Children
      • Early Childhood
      • Middle Childhood
    • Infants
    • Toddlers
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Johnson & Johnson
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd
  • Merck & Co., Inc.
  • Novartis AG
  • Sanofi S.A.
  • GlaxoSmithKline plc
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Baxter International Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Pediatric Health Market, by Product Type
8.1. Introduction
8.2. Devices
8.2.1. Imaging Devices
8.2.2. Monitoring Devices
8.2.3. Surgical Instruments
8.3. Diagnostics
8.3.1. Molecular Diagnostics
8.3.2. Point Of Care
8.4. Drugs
8.4.1. Biologics
8.4.2. Small Molecule
8.4.3. Vaccines
9. Pediatric Health Market, by Disease Type
9.1. Introduction
9.2. Endocrine
9.3. Gastrointestinal
9.4. Infectious
9.4.1. Bacterial
9.4.1.1. Staphylococcal Infections
9.4.1.2. Streptococcal Infections
9.4.2. Parasitic
9.4.2.1. Malaria
9.4.3. Viral
9.4.3.1. Respiratory Syncytial Virus
9.4.3.2. Rotavirus
9.5. Neurology
9.6. Respiratory
10. Pediatric Health Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies
11. Pediatric Health Market, by End User
11.1. Introduction
11.2. Clinics
11.2.1. Multi Specialty Clinics
11.2.2. Pediatric Clinics
11.3. Home Care
11.4. Hospitals
11.4.1. General Hospitals
11.4.2. Pediatric Hospitals
11.5. Specialty Centers
12. Pediatric Health Market, by Age Group
12.1. Introduction
12.2. Adolescents
12.2.1. Early Adolescents
12.2.2. Late Adolescents
12.3. Children
12.3.1. Early Childhood
12.3.2. Middle Childhood
12.4. Infants
12.5. Toddlers
13. Americas Pediatric Health Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Pediatric Health Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Pediatric Health Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Johnson & Johnson
16.3.2. Pfizer Inc.
16.3.3. F. Hoffmann-La Roche Ltd
16.3.4. Merck & Co., Inc.
16.3.5. Novartis AG
16.3.6. Sanofi S.A.
16.3.7. GlaxoSmithKline plc
16.3.8. Abbott Laboratories
16.3.9. Becton, Dickinson and Company
16.3.10. Baxter International Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. PEDIATRIC HEALTH MARKET MULTI-CURRENCY
FIGURE 2. PEDIATRIC HEALTH MARKET MULTI-LANGUAGE
FIGURE 3. PEDIATRIC HEALTH MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL PEDIATRIC HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. PEDIATRIC HEALTH MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. PEDIATRIC HEALTH MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. PEDIATRIC HEALTH MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PEDIATRIC HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY IMAGING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ENDOCRINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY STAPHYLOCOCCAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY STREPTOCOCCAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PARASITIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MALARIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PARASITIC, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY RESPIRATORY SYNCYTIAL VIRUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ROTAVIRUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MULTI SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PEDIATRIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PEDIATRIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY EARLY ADOLESCENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY LATE ADOLESCENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY EARLY CHILDHOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY MIDDLE CHILDHOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY INFANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY TODDLERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY PARASITIC, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY PARASITIC, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 99. CANADA PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 100. CANADA PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 101. CANADA PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 102. CANADA PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 103. CANADA PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 104. CANADA PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 105. CANADA PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 106. CANADA PEDIATRIC HEALTH MARKET SIZE, BY PARASITIC, 2018-2030 (USD MILLION)
TABLE 107. CANADA PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2030 (USD MILLION)
TABLE 108. CANADA PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. CANADA PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. CANADA PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 111. CANADA PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 112. CANADA PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 113. CANADA PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2030 (USD MILLION)
TABLE 114. CANADA PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 115. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 116. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 117. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 118. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 119. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 120. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 121. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 122. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY PARASITIC, 2018-2030 (USD MILLION)
TABLE 123. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2030 (USD MILLION)
TABLE 124. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 127. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 128. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 129. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2030 (USD MILLION)
TABLE 130. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY PARASITIC, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY PARASITIC, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2030 (USD MILLION)
TABLE 156. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 159. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 160. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 161. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY PARASITIC, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 180. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY PARASITIC, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 196. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 198. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 199. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 200. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 201. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 202. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 203. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY PARASITIC, 2018-2030 (USD MILLION)
TABLE 204. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2030 (USD MILLION)
TABLE 205. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 208. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 209. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 210. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2030 (USD MILLION)
TABLE 211. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 212. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 213. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 214. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 215. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 216. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 217. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 218. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 219. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY PARASITIC, 2018-2030 (USD MILLION)
TABLE 220. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2030 (USD MILLION)
TABLE 221. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 224. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 225. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 226. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2030 (USD MILLION)
TABLE 227. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY PARASITIC, 2018-2030 (USD MILLION)
TABLE 236. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2030 (USD MILLION)
TABLE 237. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 238. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 240. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 241. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 242. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2030 (USD MILLION)
TABLE 243. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 244. ITALY PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. ITALY PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 246. ITALY PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 247. ITALY PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 248. ITALY PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 249. ITALY PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 250. ITALY PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 251. ITALY PEDIATRIC HEALTH MARKET SIZE, BY PARASITIC, 2018-2030 (USD MILLION)
TABLE 252. ITALY PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2030 (USD MILLION)
TABLE 253. ITALY PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 254. ITALY PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. ITALY PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 256. ITALY PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 257. ITALY PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 258. ITALY PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2030 (USD MILLION)
TABLE 259. ITALY PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 260. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 261. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 262. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 263. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 264. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 265. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 266. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 267. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY PARASITIC, 2018-2030 (USD MILLION)
TABLE 268. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2030 (USD MILLION)
TABLE 269. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 270. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 272. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 273. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 274. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2030 (USD MILLION)
TABLE 275. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY PARASITIC, 2018-2030 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 292. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 294. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 296. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 298. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY PARASITIC, 2018-2030 (USD MILLION)
TABLE 300. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 302. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 304. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 306. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 308. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 309. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 310. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 312. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 314. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY PARASITIC, 2018-2030 (USD MILLION)
TABLE 316. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 318. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 320. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 322. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 324. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 325. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 326. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 327. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 328. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 329. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 330. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 331. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY PARASITIC, 2018-2030 (USD MILLION)
TABLE 332. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2030 (USD MILLION)
TABLE 333. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 334. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 335. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 336. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 337. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 338. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2030 (USD MILLION)
TABLE 339. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 340. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 341. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 342. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 343. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 344. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 345. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2030 (USD MILLION)
TABLE 346. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
TABLE 347. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY PARASITIC, 2018-2030 (USD MILLION)
TABLE 348. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2030 (USD MILLION)
TABLE 349. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 350. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 351. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 352. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 353. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 354. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2030 (USD MILLION)
TABLE 355. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 356. QATAR PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 357. QATAR PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 358. QATAR PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 359. QATAR PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 360. QATAR PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2

Companies Mentioned

The companies profiled in this Pediatric Health market report include:
  • Johnson & Johnson
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd
  • Merck & Co., Inc.
  • Novartis AG
  • Sanofi S.A.
  • GlaxoSmithKline plc
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Baxter International Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages185
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 123.07 Billion
Forecasted Market Value ( USD ) by 2030 $ 181.98 Billion
Compound Annual Growth Rate8.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Pediatric Vaccines Market by Vaccine Type, Disease, Distribution Channel, End User, Technology, Age Group - Global Forecast to 2030 - Product Image

Pediatric Vaccines Market by Vaccine Type, Disease, Distribution Channel, End User, Technology, Age Group - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Pediatric Medical Device Market by Product Type, Application, End User, Age Group, Distribution Channel - Global Forecast to 2030 - Product Image

Pediatric Medical Device Market by Product Type, Application, End User, Age Group, Distribution Channel - Global Forecast to 2030

  • Report
  • 197 Pages
  • Global
From
Pediatric Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase III), By Study Design (Treatment Studies, Observational Studies), By Indication, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Pediatric Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase III), By Study Design (Treatment Studies, Observational Studies), By Indication, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Pediatric Cardiac Tumor Diagnostic Market Size, Share & Trend Analysis Report By Tumor (Primary Cardiac Tumors, Secondary Cardiac Tumors), By Type (Echocardiography, MRI), By End-use, By Region, and Segment Forecasts, 2024 - 2030 - Product Image

Pediatric Cardiac Tumor Diagnostic Market Size, Share & Trend Analysis Report By Tumor (Primary Cardiac Tumors, Secondary Cardiac Tumors), By Type (Echocardiography, MRI), By End-use, By Region, and Segment Forecasts, 2024 - 2030

  • Report
  • 160 Pages
  • Global
From
Pediatric Medical Devices Market Report by Product, End User, and Region 2025-2033 - Product Image

Pediatric Medical Devices Market Report by Product, End User, and Region 2025-2033

  • Report
  • 136 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.